Brandetti, E., Veneziani, I., Melaiu, O., Pezzolo, A., Castellano, A., Boldrini, R., . . . Cifaldi, L. (2017). MYCN is an immunosuppressive oncogene dampening the expression of ligands for NK-cell-activating receptors in human high-risk neuroblastoma. Oncoimmunology.
শিকাগো স্টাইলে সাইটেশনBrandetti, Elisa, et al. "MYCN Is an Immunosuppressive Oncogene Dampening the Expression of Ligands for NK-cell-activating Receptors in Human High-risk Neuroblastoma." Oncoimmunology 2017.
এমএলএ সাইটেশনBrandetti, Elisa, et al. "MYCN Is an Immunosuppressive Oncogene Dampening the Expression of Ligands for NK-cell-activating Receptors in Human High-risk Neuroblastoma." Oncoimmunology 2017.
সতর্কবাণী: সাইটেশন সবসময় 100% নির্ভুল হতে পারে না.